Athena Heart 310 Link

Targeted protein levels decreased by an average of 73%.

Recent data from clinical studies, including updates as of late 2025, show significant efficacy in participants: ATHENA HEART 310

Average drops of ~55% at the highest dose, with some patients seeing up to 84% reduction . Targeted protein levels decreased by an average of 73%

ANGPTL3 is a protein that normally inhibits enzymes that clear lipids from the blood. By "turning off" this gene, the body can more effectively remove fats. including updates as of late 2025